|
AU2016202502A1
|
|
Oral Cephalotaxine Dosage Forms
|
|
AU2013270484A1
|
|
Oral Cephalotaxine Dosage Forms
|
|
EP2229160A1
|
|
Leukemic stem cell ablation
|
|
CN101677951A
|
|
Oral cephalotaxine dosage forms
|
|
AU2006202650A1
|
|
Compositions containing a naphthalimide and an antiproliferative agent
|
|
US2006211648A1
|
|
Naphthalimide compositions and uses thereof
|
|
AU2006213915A1
|
|
Medical devices
|
|
CA2569279A1
|
|
Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors
|
|
US2005142214A1
|
|
Naphthalimide compositions and uses thereof
|
|
EP1711634A2
|
|
Naphthalimide dosing by n-acetyl transferase genotyping
|
